Evidence map›Paper›PMID 41390454›Full record

ArticleJournal of medical case reports2025

Meningoencephalitis as a presentation of primary Sjögren's syndrome: a case report.

Ali Kadim Karim, Faiq I Gorial, Israa Ali Badi, Farah J Mahdi, Nabaa Ihsan Awadh, Ahmed Moaffak Hassan, Mohammad Khazaal Juma'a

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali Kadim KarimDepartment of Neurology, Baghdad Teaching Hospital, Baghdad, Iraq.
Faiq I GorialRheumatology Unit, Department of Internal Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.
Israa Ali BadiDepartment of Neurology, Baghdad Teaching Hospital, Baghdad, Iraq.
Farah J MahdiRheumatology Unit, College of Medicine, Al Mustansiriya University, Baghdad, Iraq.
Nabaa Ihsan AwadhRheumatology Unit, Department of Internal Medicine, Baghdad Teaching Hospital, Baghdad, Iraq.
Ahmed Moaffak HassanUniversity of Baghdad Bab al-Moadham Campus College of Medicine, Baghdad, FL, Iraq. Ahmed.Hasan1900@comed.uobaghdad.edu.iq.ORCID http://orcid.org/0009-0000-1059-295X
Mohammad Khazaal Juma'aRheumatology Unit, Department of Internal Medicine, Baghdad Teaching Hospital, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSjögren's syndrome is an autoimmune, chronic inflammatory disease characterized by its impact on salivary and lacrimal glands, along with potential involvement of internal organs. Sicca symptoms, such as dry eyes and mouth, are typical features. CASE PRESENTATION: We present the case of a 30-year-old Iraqi woman who presented with meningoencephalitis and acute motor axonal neuropathy, which were unusual as initial manifestations of Sjögren's syndrome. Initial investigations included a complete blood count, erythrocyte sedimentation rate, C-reactive protein, renal and liver function tests, and cerebrospinal fluid analysis. Brain magnetic resonance imaging showed hyperintense lesions in the brainstem and periventricular regions, and magnetic resonance venography was performed to rule out venous thrombosis. An aquaporin 4 antibody screening test was sent for suspected neuromyelitis optica and returned positive. However, subsequent magnetic resonance imaging scans of the spinal cord and optic nerve found no abnormalities. Serological tests confirmed the presence of antinuclear antibodies, rheumatoid factor, and antibodies against SS-A and SS-B, consistent with Sjögren's syndrome. The patient was treated with methylprednisolone and intravenous immunoglobulin. Given the suspected diagnosis of Bickerstaff encephalitis, intravenous immunoglobulin was included in the regimen, although it was later ruled out. After 4 weeks of treatment, the patient showed significant improvement, regaining consciousness and partial motor function. Several months after symptom onset, the patient achieved independent mobility despite experiencing mild weakness in the right lower limb, and plans were made to initiate either cyclophosphamide or rituximab therapy.

conclusionsThis case underscores the diverse clinical presentations of Sjögren's syndrome, highlighting the importance of considering autoimmune etiologies in patients presenting with neurological manifestations such as meningoencephalitis and acute motor axonal neuropathy. Early recognition and management of such atypical presentations are crucial for improving patient outcomes.

Indexed as

MeningoencephalitisSjogren's SyndromeAdultFemaleHumansImmunoglobulins, IntravenousMagnetic Resonance ImagingMethylprednisoloneTreatment OutcomeImmunoglobulins, IntravenousMethylprednisoloneAcute motor axonal neuropathy (AMAN)MeningoencephalitisPrimary Sjögren’s syndrome

Identifiers

PMID41390454
PMCPMC12822350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.